MD Non-small cell lung cancer (NSCLC) is a type of cancer that begins in the tissues of the lungs. About 80-85% of all lung cancer cases in the United States are classified as NSCLC. NSCLC occurs ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for predicting the prognosis of non-small-cell lung cancer (NSCLC). NSCLC is the most ...

Amid an 18 percent increase in cancer drug sales, J&J executives shared hopes that recent overall survival data for the drug combo will be practice changing.

There are around 200,000 people diagnosed with lung cancer in the US each year, with 80-85% of them having NSCLC. Of these, around 70% are diagnosed at an advanced stage and 15% have tumours with ...

Lung cancer is the leading cause of cancer-related deaths in the United States, with NSCLC accounting for up to 85% of diagnoses. While surgery has been a primary treatment option for some early ...

About 80-85% of people with lung cancer in the United States are diagnosed with NSCLC. While anybody can develop the cancer, ...

Non-small-cell lung cancer (NSCLC) treatment has led to improved efficacy and compliance due to individual tailoring of the therapeutic options and the use of strategies based on both clinical ...

Non-Small Cell Lung Cancer [NSCLC] - accounts for up to 85% of all lung cancer cases Small-Cell Lung Cancer [SCLC] - accounts for up to 15% of all lung cancer cases. Some symptoms that these ...

CAN-2409 extended median overall survival to 24.5 months in NSCLC patients, surpassing standard docetaxel chemotherapy outcomes. The treatment showed a significant survival benefit in non-squamous ...

LaunXP will take the lead on developing the therapy and EGFRi combo for NSCLC treatment within its designated territories. Apollomics CEO Dr Guo-Liang Yu stated: “We are delighted to partner ...

Common symptoms of non-small cell lung cancer (NSCLC) include frequent coughing that worsens over time, chest pain, and shortness of breath. Non-small cell lung cancer (NSCLC) is the most common ...